Clover Health Investments (CLOV) vs Trupanion (TRUP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Clover Health Investments (CLOV) has outperformed Trupanion (TRUP) over the past year, gaining 63.6% versus a loss of 0.9%. Over five years, CLOV leads with a -31.1% price change compared with -72.0% for TRUP. Clover Health Investments is the larger company by market cap ($2.00 billion vs $1.54 billion), about 1.3 times the size.
On valuation, Trupanion trades at a lower forward P/E (8.1x vs 20.7x for Clover Health Investments). Trupanion converts more of its revenue into profit, with a net margin of 1.4% versus -4.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLOV | TRUP |
|---|---|---|
| Share price | $3.73 | $35.56 |
| Market cap | $2.00B | $1.54B |
| 1-day change | -1.06% | -0.86% |
| YTD return | +58.72% | -4.84% |
| 1-year return | +63.60% | -0.95% |
| 5-year return | -31.05% | -71.95% |
| P/E ratio (TTM) | 373.00 | 58.30 |
| Forward P/E | 20.72 | 8.14 |
| EPS (TTM) | $0.01 | $0.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.92B | $1.44B |
| Revenue growth (YoY) | +40.34% | +11.95% |
| Net income (latest FY) | $-85.55M | $19.43M |
| Gross margin | — | 16.05% |
| Operating margin | -4.44% | 0.96% |
| Net margin | -4.45% | 1.35% |
| 52-week high | $5.59 | $38.87 |
| 52-week low | $1.58 | $21.16 |
| Distance from 52-week high | -33.27% | -8.52% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +50.13% | +3.35% |
| Average volume | 4.49M | 443.82K |
| Shares outstanding | 439.71M | 43.26M |
| Employees | 724 | 1,121 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CLOV has outperformed TRUP by 64.5 percentage points over the past year.
- Clover Health Investments trades at a higher earnings multiple (373.0x vs 58.3x trailing P/E).
- Trupanion is more profitable, keeping 1.4 cents of every revenue dollar as net income versus -4.4 cents for Clover Health Investments.
- Clover Health Investments grew revenue faster in its latest fiscal year (+40.34% vs +11.95%).
About Clover Health Investments
CLOV stock →Clover Health Investments, Corp. provides medicare advantage plans in the United States.
Health Care · Medical Specialities · 724 employees
About Trupanion
TRUP stock →Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business.
Health Care · Medical Specialities · 1,121 employees
CLOV vs TRUP FAQ
Which is bigger, Clover Health Investments or Trupanion?
Clover Health Investments (CLOV) is larger, with a market capitalization of $2.00B compared with $1.54B for Trupanion (TRUP).
Which stock has performed better over the past year, CLOV or TRUP?
CLOV returned +63.60% over the past 12 months, compared with -0.95% for TRUP (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CLOV or TRUP?
TRUP has the lower trailing P/E at 58.3, versus 373.0 for CLOV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Clover Health Investments and Trupanion in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.